RVPH

NASDAQStock

Reviva Pharmaceuticals Holdings, Inc.

$2.42-0.23 (-8.87%)

52-Week Range

$0.21

$4.89

Key Stats

Market Cap

8.2M

P/E Ratio

—

Dividend Yield

—

Beta

0.20

Volume

198.4K

Avg Volume

770.0K

Performance

+933.54%

+319.64%

+513.43%

YTD

+754.84%

+138.74%

-35.37%

-69.71%

Price Chart

ETF Exposure

RVPH is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	58	$23	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,094	$829	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	10	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,192,155	$349K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	6,270	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	540	$214	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	1,159,163	$339K	$84.10B	0.05%

About RVPH ETF Exposure

Reviva Pharmaceuticals Holdings, Inc. (RVPH) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 8.2M, RVPH is a widely held institutional stock. The stock currently trades at $2.42. Investors can gain exposure to RVPH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RVPH, sorted by portfolio weight.